<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Hyperbaric oxygen therapy for acute coronary syndrome - Bennett, MH - 2015 | Cochrane Library</title> <meta content="Hyperbaric oxygen therapy for acute coronary syndrome - Bennett, MH - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004818.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Hyperbaric oxygen therapy for acute coronary syndrome - Bennett, MH - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004818.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004818.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Hyperbaric oxygen therapy for acute coronary syndrome" name="citation_title"/> <meta content="Michael H Bennett" name="citation_author"/> <meta content="Prince of Wales Clinical School, University of NSW" name="citation_author_institution"/> <meta content="m.bennett@unsw.edu.au" name="citation_author_email"/> <meta content="Jan P Lehm" name="citation_author"/> <meta content="Prince of Wales Hospital" name="citation_author_institution"/> <meta content="Nigel Jepson" name="citation_author"/> <meta content="Prince of Wales Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD004818.pub4" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/07/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004818.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004818.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004818.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Coronary Syndrome [mortality, *therapy]; Angina, Unstable [mortality, *therapy]; Hyperbaric Oxygenation [*mortality]; Myocardial Infarction [mortality, *therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004818.pub4&amp;doi=10.1002/14651858.CD004818.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="tlnpj831";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004818\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004818\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","ja","hr","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004818.pub4",title:"Hyperbaric oxygen therapy for acute coronary syndrome",firstPublishedDate:"Jul 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004818.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004818.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004818.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004818.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004818.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004818.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004818.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004818.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004818.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004818.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4186 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004818.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0071"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0037"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-sec-0065"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/appendices#CD004818-sec-0076"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/table_n/CD004818StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/table_n/CD004818StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Hyperbaric oxygen therapy for acute coronary syndrome</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#CD004818-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Michael H Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#CD004818-cr-0005">Jan P Lehm</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information#CD004818-cr-0006">Nigel Jepson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information/en#CD004818-sec-0100">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 July 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004818.pub4">https://doi.org/10.1002/14651858.CD004818.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004818-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004818-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004818-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004818-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004818-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004818-abs-0001" lang="en"> <section id="CD004818-sec-0001"> <h3 class="title" id="CD004818-sec-0001">Background</h3> <p>Acute coronary syndrome (ACS), includes acute myocardial infarction and unstable angina, is common and may prove fatal. Hyperbaric oxygen therapy (HBOT) will improve oxygen supply to the threatened heart and may reduce the volume of heart muscle that perishes. The addition of HBOT to standard treatment may reduce death rate and other major adverse outcomes. </p> <p>This an update of a review previously published in May 2004 and June 2010.</p> </section> <section id="CD004818-sec-0002"> <h3 class="title" id="CD004818-sec-0002">Objectives</h3> <p>The aim of this review was to assess the evidence for the effects of adjunctive HBOT in the treatment of ACS. We compared treatment regimens including adjunctive HBOT against similar regimens excluding HBOT. Where regimens differed significantly between studies this is clearly stated and the implications discussed. All comparisons were made using an intention to treat analysis where this was possible. Efficacy was estimated from randomised trial comparisons but no attempt was made to evaluate the likely effectiveness that might be achieved in routine clinical practice. Specifically, we addressed: </p> <p>Does the adjunctive administration of HBOT to people with acute coronary syndrome (unstable angina or infarction) result in a reduction in the risk of death? </p> <p>Does the adjunctive administration of HBOT to people with acute coronary syndrome result in a reduction in the risk of major adverse cardiac events (MACE), that is: cardiac death, myocardial infarction, and target vessel revascularization by operative or percutaneous intervention? </p> <p>Is the administration of HBOT safe in both the short and long term?</p> </section> <section id="CD004818-sec-0003"> <h3 class="title" id="CD004818-sec-0003">Search methods</h3> <p>We updated the search of the following sources in September 2014, but found no additional relevant citations since the previous search in June 2010 (CENTRAL), MEDLINE, EMBASE, CINAHL and DORCTHIM. Relevant journals were handsearched and researchers in the field contacted. We applied no language restrictions. </p> </section> <section id="CD004818-sec-0004"> <h3 class="title" id="CD004818-sec-0004">Selection criteria</h3> <p>Randomised studies comparing the effect on ACS of regimens that include HBOT with those that exclude HBOT. </p> </section> <section id="CD004818-sec-0005"> <h3 class="title" id="CD004818-sec-0005">Data collection and analysis</h3> <p>Three authors independently evaluated the quality of trials using the guidelines of the Cochrane Handbook and extracted data from included trials. Binary outcomes were analysed using risk ratios (RR) and continuous outcomes using the mean difference (MD) and both are presented with 95% confidence intervals. We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD004818-sec-0006"> <h3 class="title" id="CD004818-sec-0006">Main results</h3> <p>No new trials were located in our most recent search in September 2014. Six trials with 665 participants contributed to this review. These trials were small and subject to potential bias. Only two reported randomisation procedures in detail and in only one trial was allocation concealed. While only modest numbers of participants were lost to follow‐up, in general there is little information on the longer‐term outcome for participants. Patients with acute coronary syndrome allocated to HBOT were associated with a reduction in the risk of death by around 42% (RR: 0.58, (95% CI 0.36 to 0.92), 5 trials, 614 participants; low quality evidence). </p> <p>In general, HBOT was well‐tolerated. No patients were reported as suffering neurological oxygen toxicity and only a single patient was reported to have significant barotrauma to the tympanic membrane. One trial suggested a significant incidence of claustrophobia in single occupancy chambers of 15% (RR of claustrophobia with HBOT 31.6, 95% CI 1.92 to 521). </p> </section> <section id="CD004818-sec-0007"> <h3 class="title" id="CD004818-sec-0007">Authors' conclusions</h3> <p>For people with ACS, there is some evidence from small trials to suggest that HBOT is associated with a reduction in the risk of death, the volume of damaged muscle, the risk of MACE and time to relief from ischaemic pain. In view of the modest number of patients, methodological shortcomings and poor reporting, this result should be interpreted cautiously, and an appropriately powered trial of high methodological rigour is justified to define those patients (if any) who can be expected to derive most benefit from HBOT. The routine application of HBOT to these patients cannot be justified from this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004818-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004818-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004818-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004818-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004818-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004818-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004818-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004818-abs-0010">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004818-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004818-abs-0002" lang="en"> <h3>Does hyperbaric oxygen therapy improve outcome after heart attack?</h3> <p><b>Background</b> </p> <p>Acute heart attacks and severe angina (heart pain) are usually due to blockages in the arteries supplying the heart (coronary arteries). These problems are collectively referred to as 'acute coronary syndrome' (ACS). ACS is very common and may lead to severe complications including death. Hyperbaric oxygen therapy (HBOT) involves people breathing pure oxygen at high pressures in a specially designed chamber. It is sometimes used as a treatment to increase the supply of oxygen to the damaged heart in an attempt to reduce the area of the heart that is at risk of dying. </p> <p>We searched the medical literature for any studies that reported the outcome of patients with ACS when treated with HBOT. </p> <p><b>Studies found</b> </p> <p>We first searched the literature in 2004 and most recently in September 2014, finding 6 studies in total. All studies included patients with heart attack and some also included patients with severe angina. The dose of hyperbaric oxygen was similar in most studies. </p> <p><b>Key results</b> </p> <p>Overall, we found some evidence that people with ACS are less likely to die or to have major adverse events, and to have more rapid relief from their pain if they receive hyperbaric oxygen therapy as part of their treatment. However, our conclusions are based on relatively small randomised trials. Our confidence in these findings is further reduced because in most of these studies both the patients and researchers were aware of who was receiving HBOT and it is possible a 'placebo effect' has biased the result in favour of HBOT. HBOT was generally well‐tolerated. Some patients complained of claustrophobia when treated in small (single person) chambers and there was no evidence of important toxicity from oxygen breathing in any subject. One individual suffered damage to the eardrum from pressurisation. </p> <p><b>Conclusions</b> </p> <p>While HBOT may reduce the risk of dying, time to pain relief and the chance of adverse heart events in people with heart attack and unstable angina, more work is needed to be sure that HBOT should be recommended. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004818-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004818-sec-0071"></div> <h3 class="title" id="CD004818-sec-0072">Implications for practice</h3> <section id="CD004818-sec-0072"> <p>There is some evidence from this review that HBOT following an episode of ACS reduces the risk of death, re‐infarction, significant dysrhythmias and MACE, as well as limiting the peak levels of CPK and improving left ventricular ejection fraction. HBOT may also reduce the time required to achieve relief from cardiac ischaemic pain in these patients. The small number of studies, the modest numbers of patients, and the methodological and reporting inadequacies of the primary studies included in this review demand a cautious interpretation. Thus, the routine adjunctive use of HBOT in these patients cannot be justified by this review. </p> </section> <h3 class="title" id="CD004818-sec-0073">Implications for research</h3> <section id="CD004818-sec-0073"> <p>Given the indicative findings of improved outcomes with the use of HBOT in these patients, there is a case for large randomised trials of high methodological rigour in order to define the true extent of benefit (if any) from the administration of HBOT. Specifically, more information is required on the subset of disease severity and timing of therapy most likely to result in benefit from this therapy. Given the activity of HBOT in modifying ischaemia‐reperfusion injury, attention should be given to combinations of HBOT and thrombolysis in the early treatment of acute coronary events and the prevention of re‐stenosis after stent placement. Any future trials would need to consider in particular: </p> <p> <ul id="CD004818-list-0008"> <li> <p>appropriate sample sizes with power to detect the expected differences suggested by this review; </p> </li> <li> <p>careful definition and selection of target patients;</p> </li> <li> <p>acute versus sub‐acute administration of HBOT;</p> </li> <li> <p>appropriate range of oxygen doses per treatment session (pressure and time);</p> </li> <li> <p>appropriate and carefully defined comparator therapy;</p> </li> <li> <p>use of an effective sham therapy;</p> </li> <li> <p>effective and explicit blinding of outcome assessors;</p> </li> <li> <p>appropriate outcome measures including all those listed in this review;</p> </li> <li> <p>careful elucidation of any adverse effects;</p> </li> <li> <p>the cost‐utility of the therapy;</p> </li> <li> <p>patient quality of life.</p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004818-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004818-sec-0008"></div> <div class="table" id="CD004818-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>hyperbaric oxygen therapy for acute coronary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute coronary syndrome<br/><b>Settings:</b> Acute care hospital<br/><b>Intervention:</b> hyperbaric oxygen therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>hyperbaric oxygen therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death at any time</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.58</b> <br/>(0.36 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>614<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>116 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b><br/>(42 to 107) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>102 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/>(37 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Critical outcome<br/><sup>2</sup> Small sample with low numbers of events </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004818-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>hyperbaric oxygen therapy for acute coronary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute coronary syndrome<br/><b>Settings:</b> acute care hospital<br/><b>Intervention:</b> hyperbaric oxygen therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>hyperbaric oxygen therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12 hour Plasma Creatine Phosphokinase</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 12 hour Plasma Creatine Phosphokinase in the intervention groups was<br/><b>138 lower</b><br/>(843.83 lower to 567.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>24 hour Plasma Creatine Phosphate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 24 hour Plasma Creatine Phosphate in the intervention groups was<br/><b>65 lower</b><br/>(530.96 lower to 400.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maximum Plasma Creatine Phosphate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Maximum Plasma Creatine Phosphate in the intervention groups was<br/><b>493.16 lower</b><br/>(838.74 to 147.58 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single trial only </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004818-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004818-sec-0009"></div> <section id="CD004818-sec-0010"> <h3 class="title" id="CD004818-sec-0010">Description of the condition</h3> <p>Cardiovascular disease (CVD) is the leading cause of death in the world, accounting for 30% of all deaths, of which 42% are due to coronary heart disease (CHD) (<a href="./references#CD004818-bbs2-0043" title="World Health Organisation. Cardiovascular diseases (CVDs). Fact sheet N°317 Updated March 2013. http://www.who.int/mediacentre/factsheets/fs317/en/ (accessed on 19 December 2014).">WHO 2013</a>). In the United Kingdom, CVD is the most common cause of premature death, causing just over 159,000 deaths, approximately 25% of all deaths episodes in 2011 (<a href="./references#CD004818-bbs2-0014" title="British Heart Foundation. https://www.bhf.org.uk/publications/statistics/coronary-heart-disease-statistics-2012. London: British Heart Foundation, 3/12/2012.">BHF 2012</a>). Of these deaths, nearly 74,000 were due to CHD at a community cost of around GBP 1.8 billion in 2009 (<a href="./references#CD004818-bbs2-0034" title="NicholsM , TownsendN , Luengo-FernandezR , LealJ , GreyA , ScarboroughP , RaynerM . European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis. Brussels: European Society of Cardiology, Sophia Antipolis, 2012.">Nichols 2012</a>). Since myocardial infarction (the presence of two out of three of: chest pain, ECG changes and cardiac enzyme rise) is not always diagnosable during an acute event, unstable or persisting ischaemic heart pain (angina) with or without infarction are together described as acute coronary syndrome (ACS). The main underlying problems in coronary heart disease is atherosclerosis, a degenerative process characterised by the formation of plaques comprised of platelets, cells, matrix fibres, lipids, and tissue debris in the vessel lumen. While such plaques are often complicated by ulceration of the vessel wall with obstruction to blood flow, such ulceration is not necessary for plaques to be problematic (<a href="./references#CD004818-bbs2-0033" title="NaghaviM , LibbyP , FalkE , CasscellsSW , LitovskyS , et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation2003;108(14):1664-72.">Naghavi 2003</a>). An unstable plaque (coronary atheroma vulnerable to rupture and fissure, and associated with thrombus formation) can lead to an acute coronary syndrome without the artery being totally occluded and infarction may follow (<a href="./references#CD004818-bbs2-0021" title="HeistadD . Unstable coronary-artery plaques. New England Journal of Medicine2003;349(24):2285-7.">Heistad 2003</a>). A significant proportion of patients admitted with acute myocardial infarction (AMI) will suffer major morbidity or mortality, even when thrombolysis or angioplasty is used to relieve the obstruction, although there is some evidence that the rate of inhospital events and six‐month readmissions are falling with increasing adherence to evidence‐based guidelines (<a href="./references#CD004818-bbs2-0026" title="KallaK , ChristG , KarnikR , MalzerR , NormanG , PracharH , et al. Implementation of guidelines improves the standard of care the Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation2006;113:2398-405.">Kalla 2006</a>; Aliprandi‐Costa 2011). </p> </section> <section id="CD004818-sec-0011"> <h3 class="title" id="CD004818-sec-0011">Description of the intervention</h3> <p>Hyperbaric oxygen therapy (HBOT) is an adjunctive therapy that has been proposed to improve outcome following ACS. HBOT is the therapeutic administration of 100% oxygen at environmental pressures greater than one atmosphere absolute (ATA), and involves placing the patient in an airtight vessel, increasing the pressure within that vessel, and administering 100% oxygen for respiration. In this way, it is possible to deliver a greatly increased partial pressure of oxygen to the tissues. At 2 ATA, for example, patients with reasonable cardiopulmonary function will have an arterial oxygen tension of over 1000 mmHg, and a muscle oxygen tension around 221mmHg (<a href="./references#CD004818-bbs2-0035" title="SheffieldP . Tissue oxygen measurements. In: Problem Wounds. The Role of Oxygen. 1st edition. New York: Elsevier Science Publishing, 1988:17-51.">Sheffield 1988</a>; <a href="./references#CD004818-bbs2-0042" title="WellsCH , GoodpastureJE , HorriganDJ . Tissue gas measurements during hyperbaric oxygen exposure. In: SmithG , editors(s). Proceedings of the Sixth International Congress on Hyperbaric Medicine. Aberdeen: Aberdeen University Press, 1977:118-24.">Wells 1977</a>). In comparison, muscle oxygen tension on air at 1ATA is about 29 mmHg and 59mmHg breathing 100% oxygen at 1ATA. Indeed, at 3ATA on 100% oxygen, there are more than 6 mls of oxygen dissolved in every 100 mls of plasma, enough to sustain basal metabolic requirements without any oxygen transport by haemoglobin (<a href="./references#CD004818-bbs2-0015" title="BoeremaI , MeyneNG , BrummelkampWK , BoumaS , MenschMH , KamermansF , et al. Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of blood. Journal of Cardiovascular Surgery1960;1(1):133-46.">Boerema 1960</a>; <a href="./references#CD004818-bbs2-0019" title="HammarlundC . The physiologic effects of hyperbaric oxygenation. In: KindwallEP , WhelanHT , editors(s). Hyperbaric Medicine Practice. 2nd edition. Flagstaff Az: Best Publishing Company, 1999:37-68.">Hammarlund 1999</a>; <a href="./references#CD004818-bbs2-0030" title="LeachRM , ReesPJ , WilmshurstP . ABC of oxygen. Hyperbaric oxygen therapy. BMJ1998;317:1140-3.">Leach 1998</a>). However 3ATA of 100% oxygen becomes rapidly toxic in the brain, manifested in epileptiform grand mal seizures. Therefore in practice, treatments involve pressurisation to between 1.5 and 2.8 ATA for periods between 60 and 120 minutes once or more daily. </p> <p>HBOT for ACS was first reported in a canine experimental model in 1958 (<a href="./references#CD004818-bbs2-0037" title="SmithG , LawsonDA . Experimental coronary arterial occlusion: effects of the administration of oxygen under pressure. Scottish Medical Journal1958;3:346-50.">Smith 1958</a>) and in a human subject in 1964 (<a href="./references#CD004818-bbs2-0032" title="MoonAJ , WilliamsKG , HopkinsonWI . A patient with coronary thrombosis treated with hyperbaric oxygen. Lancet1964;1:18-20.">Moon 1964</a>). Several uncontrolled human studies have been published since that time, generally with indications of benefit measured as a reduction in mortality or improvements in haemodynamic or metabolic parameters (<a href="./references#CD004818-bbs2-0012" title="AshfieldR , DrewCE , GaveyCJ . Severe acute myocardial infarction treated with hyperbaric oxygen. Postgraduate Medical Journal1969;45:648-53.">Ashfield 1969</a>; <a href="./references#CD004818-bbs2-0029" title="KlineHJ , MaranoAJ , JohnsonCD , GoodmanP , JacobsonJH , KuhnLA . Hemodynamic and metabolic effects of hyperbaric oxygenation in myocardial infarction. Journal of Applied Pathology1970;28:256-63.">Kline 1970</a>). As far as the authors are aware, however, HBOT is not in routine use anywhere for patients presenting with ACS. </p> </section> <section id="CD004818-sec-0012"> <h3 class="title" id="CD004818-sec-0012">How the intervention might work</h3> <p>The administration of HBOT is based on the argument that the myocardium is hypoxic, and that HBOT can reverse that hypoxia in areas that are marginally perfused. This effect is achieved by greatly increasing the diffusion gradient down which oxygen moves from the blood to the myocyte. Improved oxygen availability may also improve outcome through the effects of oxygen as a modulator of tissue repair. Oxygen has been shown to increase the expression of antioxidant enzymes in both tissues and plasma through an increase in glutathione levels (<a href="./references#CD004818-bbs2-0020" title="HarabinAL , BraistedJC , FlynnET . Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. Journal of Applied Physiology1990;69(1):328-35.">Harabin 1990</a>; <a href="./references#CD004818-bbs2-0038" title="SpeitG , DennogC , EichornU , RothfussA , KainaB . Induction of heme oxygenase-1 and adaptive protection against the induction of DNA damage after hyperbaric oxygen treatment. Cardiogenesis2000;21(10):1795-9.">Speit 2000</a>), to reduce the degree of lipid peroxidation (<a href="./references#CD004818-bbs2-0039" title="ThomSR , ElbukenM . Oxygen-dependent antagonism of lipid peroxidation in the rat. Free Radical Biology and Medicine1991;10(6):413-26.">Thom 1991</a>) and to prevent the activation of neutrophils in response to endothelial damage, thus modifying ischaemia‐reperfusion injury (<a href="./references#CD004818-bbs2-0025" title="JonesSR , CarpinKM , WoodwardSM , KhiabaniKT , StephensonLL , WangWZ , et al. Hyperbaric oxygen Inhibits ischemia-reperfusion–induced neutrophil CD18Polarization by a nitric oxide mechanism. Plastic and Reconstructive Surgery2010;126(2):403-11.">Jones 2010</a>; <a href="./references#CD004818-bbs2-0041" title="TjarnstromJ , WikstromT , BaggeU . Effects of hyperbaric oxygen treatment on neutrophil activation and pulmonary sequestration in intestinal ischemia-reperfusion in rats. European Surgical Research1999;31(2):147-54.">Tjarnstrom 1999</a>). HBOT also mobilises stem cells from the bone marrow in a dose‐dependent manner and may be important in neovascularisation of healing tissue (<a href="./references#CD004818-bbs2-0022" title="HeyboerM , MilovanovaTN , WojcikS , GrantW , ChinM , HardyKR , et al. CD34+/CD45-dim stem cell mobilization by hyperbaric oxygen - changes withb oxygen dosing. Stem Cell Research2014;12(3):638-45.">Heyboer 2014</a>). The induction of protective mechanisms via a degree of oxidative stress is probably the common factor for many of these beneficial effects (<a href="./references#CD004818-bbs2-0040" title="ThomS . Oxidative stress is fundamental to hyperbaric oxygen therapy. Journal of Applied Physiology2009;106:988-95.">Thom 2009</a>). However despite more than 40 years of interest in the delivery of HBOT relatively little clinical evidence exists for the assertion that such an intervention improves outcome. </p> </section> <section id="CD004818-sec-0013"> <h3 class="title" id="CD004818-sec-0013">Why it is important to do this review</h3> <p>To our knowledge, there are no other systematic reviews of the clinical use of HBOT for ACS, and it is important to clearly assess both the risks and benefits of this treatment. While HBOT may produce benefit for the myocardium via the mechanisms outlined above, HBOT is associated with some risk of adverse effects including damage to the ears, sinuses and lungs from the effects of pressure (<a href="./references#CD004818-bbs2-0036" title="ShupakA , GilbeyP . Effects of pressure. In: NeumanT , ThomS , editors(s). Physiology and Medicine of Hyperbaric Oxygen Therapy. 1st edition. Philadelphia: Saunders Elsevier, 2008:513-26.">Shupak 2008</a>), temporary worsening of short‐sightedness (<a href="./references#CD004818-bbs2-0027" title="KhanB , EvansAW , EasterbrookM . Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea and Hyperbaric Medicine2003;24:9.">Khan 2003</a>), claustrophobia and oxygen poisoning (<a href="./references#CD004818-bbs2-0016" title="ButlerFK , HaganC . Ocular complications in hyperbaric oxygen therapy. In: NeumanT , ThomS , editors(s). Physiology and Medicine of Hyperbaric Oxygen Therapy. 1st edition. Philadelphia: Saunders Elsevier, 2008:265-72.">Butler 2008</a>; <a href="./references#CD004818-bbs2-0030" title="LeachRM , ReesPJ , WilmshurstP . ABC of oxygen. Hyperbaric oxygen therapy. BMJ1998;317:1140-3.">Leach 1998</a>). Reported rates vary widely but, for example, about 20% of patients will experience some degree of middle ear barotrauma, and 60% to 70% a measurable worsening of short‐sightedness (<a href="./references#CD004818-bbs2-0027" title="KhanB , EvansAW , EasterbrookM . Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea and Hyperbaric Medicine2003;24:9.">Khan 2003</a>; <a href="./references#CD004818-bbs2-0036" title="ShupakA , GilbeyP . Effects of pressure. In: NeumanT , ThomS , editors(s). Physiology and Medicine of Hyperbaric Oxygen Therapy. 1st edition. Philadelphia: Saunders Elsevier, 2008:513-26.">Shupak 2008</a>). Oxygen poisoning may occur acutely in the form of grand mal seizures while exposed to hyperbaric oxygen (acute neurological toxicity), or develop over the course of treatment, resulting in a reversible reduction in vital capacity and other respiratory indices (pulmonary oxygen toxicity) (<a href="./references#CD004818-bbs2-0017" title="ClarkeJM . Oxygen toxicity. In: NeumanT , ThomS , editors(s). Physiology and Medicine of Hyperbaric Oxygen Therapy. 1st edition. Philadelphia: Saunders Elsevier, 2008:527-564.">Clark 2008</a>). In addition, the occurrence of significant post‐infarction events such as malignant arrhythmia, might be associated with a worse prognosis if they arise while the patient is confined in a hyperbaric chamber. Although serious adverse events are rare, HBOT cannot be regarded as an entirely benign intervention (<a href="./references#CD004818-bbs2-0030" title="LeachRM , ReesPJ , WilmshurstP . ABC of oxygen. Hyperbaric oxygen therapy. BMJ1998;317:1140-3.">Leach 1998</a>). For a number of reasons, therefore, the administration of HBOT for acute coronary syndrome patients remains controversial. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004818-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004818-sec-0014"></div> <p>The aim of this review was to assess the evidence for the effects of adjunctive HBOT in the treatment of ACS. We compared treatment regimens including adjunctive HBOT against similar regimens excluding HBOT. Where regimens differed significantly between studies this is clearly stated and the implications discussed. All comparisons were made using an intention to treat analysis where this was possible. Efficacy was estimated from randomised trial comparisons but no attempt was made to evaluate the likely effectiveness that might be achieved in routine clinical practice. Specifically, we addressed: </p> <p> <ul id="CD004818-list-0001"> <li> <p>Does the adjunctive administration of HBOT to people with acute coronary syndrome (unstable angina or infarction) result in a reduction in the risk of death? </p> </li> <li> <p>Does the adjunctive administration of HBOT to people with acute coronary syndrome result in a reduction in the risk of major adverse cardiac events (MACE), that is: cardiac death, myocardial infarction, and target vessel revascularization by operative or percutaneous intervention? </p> </li> <li> <p>Is the administration of HBOT safe in both the short and long term?</p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004818-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004818-sec-0015"></div> <section id="CD004818-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004818-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials that compare the effect of treatment for ACS (including thrombolysis) where HBOT administration is included, with the effect of similar treatment in the absence of HBOT. Studies were considered irrespective of the use of a sham therapy, allocation concealment or blinding status. </p> </section> <section id="CD004818-sec-0018"> <h4 class="title">Types of participants</h4> <p>Any adult with an acute coronary syndrome, with or without S‐T segment elevation.</p> </section> <section id="CD004818-sec-0019"> <h4 class="title">Types of interventions</h4> <p>HBOT administered in a compression chamber between pressures of 1.3ATA and 3.0ATA and treatment times between 30 minutes and 120 minutes on at least one occasion, were eligible. We accepted any standard treatment regimen designed to maximise recovery, and where the same regimen is delivered in both arms of any single trial. Subgroup analysis was intended to evaluate the impact of different comparator strategies. </p> </section> <section id="CD004818-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>Studies were eligible for inclusion if they reported any of the following outcome measures at any time. </p> <section id="CD004818-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004818-list-0002"> <li> <p>Death rate at any time following presentation;</p> </li> <li> <p>Rate of Major Adverse Cardiac Events (MACE), this includes death, recurrent MI, urgent revascularization (CABG or PTCA). </p> </li> </ol> </p> </section> <section id="CD004818-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004818-list-0003"> <li> <p>Rate of significant cardiac events including dysrhythmia, onset of cardiac failure, haemodynamic change; </p> </li> <li> <p>Time to relief of cardiac pain;</p> </li> <li> <p>Size of infarct area;</p> </li> <li> <p>Magnitude of cardiac enzyme changes;</p> </li> <li> <p>Left ventricular function;</p> </li> <li> <p>Length of stay in either a specialist cardiac unit or general hospital ward;</p> </li> <li> <p>Myocardial perfusion measured by whatever means;</p> </li> <li> <p>Quality of life (QOL);</p> </li> <li> <p>Rate of re‐admission;</p> </li> <li> <p>Costs for the delivery of care;</p> </li> <li> <p>Adverse events associated with HBOT including damage to the ears, sinuses and lungs from the effects of pressure, worsening of myopia, claustrophobia and oxygen poisoning. Any other adverse events reported in either arm will also be recorded. </p> </li> </ol> </p> </section> </section> </section> <section id="CD004818-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>It was our intention to capture both published and unpublished studies. We applied no language restrictions. </p> <section id="CD004818-sec-0024"> <h4 class="title">Electronic searches</h4> <p>Initial searches were made in May 2004 (<a href="./appendices#CD004818-sec-0077">Appendix 1</a>) and repeated with some modifications in strategy in June 2007 (<a href="./appendices#CD004818-sec-0082">Appendix 2</a>), June 2010 (<a href="./appendices#CD004818-sec-0087">Appendix 3</a>) and September 2014 (<a href="./appendices#CD004818-sec-0092">Appendix 4</a>). </p> <p>We searched: the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 8, September 2014) on the <i>Cochrane Library</i>, OVID MEDLINE (1966 to September 2014), OVID EMBASE (1980 to September 2014), EBSCO CINAHL (1982 to September 2014), LILACS on Bireme (1980 to September 2014) and an additional database developed in our Hyperbaric facility, DORCTHIM (The Database of Randomised Trials in Hyperbaric Medicine, <a href="./references#CD004818-bbs2-0013" title="Bennett. The database of randomised controlled trials in hyperbaric medicine. www.hboevidence.com (accessed on 21 February 2005).">Bennett 2002</a> ‐ searched September 2014. The LILACS and DORCTIHM searches were by the keywords 'coronary or cardiac or heart or myocard$' and 'hyperbaric oxygen$'. </p> </section> <section id="CD004818-sec-0025"> <h4 class="title">Searching other resources</h4> <p>In addition we undertook a systematic search for relevant controlled trials in specific hyperbaric literature sources up to September 2014: </p> <p> <ol id="CD004818-list-0004"> <li> <p>Experts in the field and leading hyperbaric therapy centres (as identified by personal communication and searching the Internet) were contacted and asked for additional relevant data in terms of published or unpublished randomised trials; </p> </li> <li> <p>Handsearching of relevant hyperbaric textbooks (<a href="./references#CD004818-bbs2-0024" title="JainKK . Textbook of Hyperbaric Medicine. 5th edition. Seattle: Hogrefe and Huber, 2009.">Jain 2009</a>; <a href="./references#CD004818-bbs2-0028" title="KindwallEP , WhelanHT . Hyperbaric Medicine Practice. 3rd edition. Flagstaff: Best Publishing Company, 2008.">Kindwall 2008</a>; <a href="./references#CD004818-bbs2-0031" title="MathieuD . Handbook on Hyperbaric Medicine. 2nd edition. Milan: Springer, 2006.">Mathieu 2006</a>), journals (Undersea and Hyperbaric Medicine, Hyperbaric Medicine Review, South Pacific Underwater Medicine Society (SPUMS) Journal, European Journal of Hyperbaric Medicine and Aviation, Space and Environmental Medicine Journal) and conference proceedings (Undersea and Hyperbaric Medical Society, SPUMS, European Undersea and Baromedical Society, International Congress of Hyperbaric Medicine) published since 1980; </p> </li> <li> <p>Contact with authors of relevant studies to request details of unpublished or ongoing investigations. </p> </li> <li> <p>We also searched for ongoing relevant trials in the registry <a href="http://ClinicalTrias.gov" target="_blank">ClinicalTrias.gov</a> using the term 'hyperbaric oxygen'. </p> </li> </ol> </p> <p>Authors were contacted if there was any ambiguity about the published data.</p> </section> </section> <section id="CD004818-sec-0026"> <h3 class="title" id="CD004818-sec-0026">Data collection and analysis</h3> <section id="CD004818-sec-0027"> <h4 class="title">Selection of studies</h4> <p>One author (MB) was responsible for handsearching and identification of appropriate studies for consideration. Two authors (MB and NJ) examined the electronic search results and identified studies that were possibly relevant. All studies considered possibly relevant by at least one author were entered into a bibliographic software package (Reference Manager). All comparative clinical trials identified were retrieved in full and reviewed independently by three authors, two with content expertise with HBOT and one with content expertise in treating ACS. In addition one of the authors (MB) has expertise in clinical epidemiology. </p> </section> <section id="CD004818-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Using a data extraction form developed for this review, each author extracted relevant data. Any disagreements were resolved by consensus and communication with the authors of the original trials as appropriate. All data extracted reflected original allocation group where possible to allow an intention to treat analysis. Withdrawals were identified where this information was given. </p> </section> <section id="CD004818-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We followed the guidelines of the Cochrane Handbook for Systematic Reviews of Interventions for assessing the risk of bias in included studies (<a href="./references#CD004818-bbs2-0023" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Book Series. Chichester: Wiley-Blackwell, 2008.">Higgins 2008</a>). Two authors (MB and JL) independently assessed the quality of the studies with respect to sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other potential threats to validity. We assessed the quality factors of each study separately and have presented them in a Risk of Bias table for each study.<br/>Any differences of opinion were resolved by discussion and consensus. </p> </section> <section id="CD004818-sec-0030"> <h4 class="title">Dealing with missing data</h4> <p>We employed sensitivity analyses using different approaches to impute missing data. The best‐case scenario assumed that none of the originally enrolled patients missing from the primary analysis in the treatment group had the negative outcome of interest whilst all those missing from the control group did. The worst‐case scenario was the reverse. </p> </section> <section id="CD004818-sec-0031"> <h4 class="title">Assessment of heterogeneity</h4> <p>For dichotomous outcomes relative risk (RR) was used. We used a fixed‐effect model where there was no evidence of significant heterogeneity between studies, and a random‐effects model where inter‐study heterogeneity was likely (see below under subgroups). </p> </section> <section id="CD004818-sec-0032"> <h4 class="title">Data synthesis</h4> <section id="CD004818-sec-0033"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004818-list-0005"> <li> <p>Risk of death (time of outcome was determined by trial data). The RR for survival with HBOT was established using the intention to treat data of the HBOT versus the control group. Where there were withdrawals without an indication as to group allocation, we divided them in the proportions intended by randomisation. Analyses were performed with RevMan 5.0.23 software. As an estimate of the statistical significance of a difference between experimental interventions and control interventions we calculated RR, with 95% confidence intervals (CI), for survival using HBOT. A statistically significant difference between experimental intervention and control intervention was assumed if the 95% CI of the RR did not include the value 1.0. As an estimate of the clinical relevance of any difference between experimental intervention and control intervention we calculated the number‐needed‐to‐treat (NNT) with 95% CI as appropriate; </p> </li> <li> <p>Risk of suffering Major Adverse Cardiac Event (MACE ‐ includes death, recurrent MI and urgent revascularization (CABG or PTCA)). The RR for MACE with and without HBOT was calculated using the methods described in (1) above; </p> </li> </ol> </p> </section> <section id="CD004818-sec-0034"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004818-list-0006"> <li> <p>Risk of suffering significant cardiac events (dysrhythmia requiring intervention, haemodynamic disturbance requiring intervention or cardiac failure). The RR for cardiac event with and without HBOT was calculated using the methods described in (1) above; </p> </li> <li> <p>Time to relief of cardiac pain: the weighted mean differences (WMD) in time to relief between HBOT and control groups was compared using RevMan 4.2. A statistically significant difference was defined as existing if the 95% CI did not include a zero WMD; </p> </li> <li> <p>Infarct area: the WMD in infarct area was to be compared using the methods described in (4) above; </p> </li> <li> <p>Rise in cardiac enzymes: the WMD between groups for the maximum enzyme level was compared as for (4) above; </p> </li> <li> <p>Left ventricular function: the WMD of ejection fraction or other measure of left ventricular function was compared as for (4) above; </p> </li> <li> <p>Length of Stay: the WMD in length of stay in both intensive care area/coronary care area and general hospital ward was calculated in a way analogous to that described in (4) above; </p> </li> <li> <p>Myocardial perfusion: the WMD in measures designed to assess myocardial perfusion were to be compared as for (4) above; </p> </li> <li> <p>Quality of life: WMD in QOL measures and/or activities of daily living were to be compared as for (4) above; </p> </li> <li> <p>Risk of re‐admission following treatment for acute coronary syndrome: the RR for re‐admission following HBOT and comparator was to be compared using the methods described in (1) above; </p> </li> <li> <p>Cost: the WMD in costs between treatment arms was to be compared as for (4) above;</p> </li> <li> <p>Dichotomous data were considered for adverse events (number of patients with adverse events versus number of patients without them in both groups) in the HBOT groups of the included studies. We tabulated any recorded adverse events and pooled as appropriate. </p> </li> </ol> </p> </section> </section> <section id="CD004818-sec-0035"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We considered, but excluded, subgroup analysis based on:</p> <p> <ol id="CD004818-list-0007"> <li> <p>Inclusion or otherwise of thrombolysis in both arms of the trial;</p> </li> <li> <p>Nature of comparator treatment modalities;</p> </li> <li> <p>Dose of oxygen received (pressure, time and length of treatment course);</p> </li> <li> <p>Presence or absence of cardiac failure;</p> </li> <li> <p>Site of infarct;</p> </li> <li> <p>Infarcted subjects versus pre‐infarction subjects.</p> </li> </ol> </p> <p>Subgroup analysis by sex and age was not considered in this analysis because we did not intend to seek individual patient data. Clinical and statistical heterogeneity was explored and subgroup analyses would have been performed if appropriate. Clinically we considered differences in patient groups, the timing and nature of all therapies and other aspects of the clinical setting. Statistically, the forest plots generated were examined and the presence or absence of overlap in the confidence intervals noted (lack of overlap of confidence intervals may indicate heterogeneity). Statistical heterogeneity was to be assumed if the I<sup>2</sup> value exceeded 30%, and consideration would have been given to the appropriateness of pooling and meta‐analysis. </p> </section> <section id="CD004818-sec-0036"> <h4 class="title">Sensitivity analysis</h4> <p>We intended to perform sensitivity analyses for missing data and study quality where appropriate data existed. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004818-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004818-sec-0037"></div> <section id="CD004818-sec-0038"> <h3 class="title">Description of studies</h3> <section id="CD004818-sec-0039"> <h4 class="title">Results of the search</h4> <p>Our previous searches from May 2004 to June 2010 produced a total of 158 records. After removal of duplicates, 44 records remained. On the basis of screening the titles and abstracts, we excluded 28 records, leaving 16 records that were examined in full. Of these, we included 11 reports of six trials. Our most recent search in September 2014 retrieved a further 66 records. After removal of duplicates, 38 records remained. After screening the titles and abstracts, we excluded all these records. This latest search has therefore uncovered no further trials that contribute to either the qualitative or quantitative review. </p> <p>The results of all four searches are combined and summarised in <a href="#CD004818-fig-0001">Figure 1</a>. In total we have included eleven reports of six trials (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>; <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>; <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>; <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>). </p> <div class="figure" id="CD004818-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD004818-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD004818-sec-0040"> <h4 class="title">Included studies</h4> <p>This review includes eleven reports of six trials (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>; <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>; <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>; <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>). The secondary citations for these studies are listed in <a href="./references#CD004818-bbs1-0001" title="">Included studies</a>. The six included trials were published between 1973 and 2007 and from a wide range of geographical locations (USA: Long Beach California <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and Cleveland Ohio <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; Russia: Minsk <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>; The Balkans: Belgrade, Serbia and Montenegro <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; England: London <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> and Australia: Fremantle <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>). None of the trials declared any industry funding, although <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> declared the chamber manufacturer loaned his group the hyperbaric chambers used. The authors of this review are unaware of any ongoing RCTs in the area. In total, the six trials enrolled 665 participants, 337 receiving HBOT and 328 control. The largest trial (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) accounts for 33% of cases. (See <a href="./references#CD004818-sec-0105" title="">Characteristics of included studies</a>).<br/><br/>All studies involved the administration of 100% oxygen at between 2ATA and 3ATA for between 30 and 120 minutes, however the total number of treatment sessions varied between studies. The lowest number administered was a single session (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>; <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>), while the highest was a maximum of 16 treatments within 48 hours (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>). </p> <p>All trials included participants with acute myocardial infarction and <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> also included individuals presenting with unstable angina. All trials included patients with similar age and sex distribution (see <a href="./references#CD004818-sec-0105" title="">Characteristics of included studies</a>). Only <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> described allocation concealment and blinded subjects to allocation with a sham HBOT session. The time from presentation to enrolment varied from "up to ten days" (<a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>), "within one week" (<a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>) to "within 24 hours" (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) and "within six hours" (<a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>). The mean time to treatment with HBOT was 13 hours in <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>, whilst <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> did not state any time. The primary purpose of five of these reports was the treatment of AMI with HBOT (<a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> was aimed at the prevention of further AMI rather than acute treatment), while for <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> it was the use of HBOT in AMI patients to identify myocardial segments capable of functional improvement, and for <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> the effect of HBOT on re‐stenosis following percutaneous coronary interventions. Specific exclusion criteria varied between trials. All trials excluded those unfit for HBOT, but in addition <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> excluded subjects who were not suitable for thrombolysis (e.g. recent stroke), those with previous AMI and those in cardiogenic shock, while <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> excluded those with uncontrolled heart failure and/or significant ongoing angina. <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> excluded subjects over 70 years and those presenting when there was no HBOT chamber available. <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> also excluded patients over 70 or with heart failure, significant dysrhythmia or no definitive diagnosis of AMI. <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> excluded those who continued to show evidence of ischaemia after 30 minutes of medical treatment. <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> only enrolled patients more than three days after AMI. </p> <p>Comparator therapies also varied between trials. All trials employed HBOT as an adjunctive procedure to "standard" care: <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> used thrombolysis, aspirin, heparin and intravenous nitroglycerine in suitable patients, <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> employed stenting and a regimen using aspirin, heparin and clopidogrel, <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> used thrombolysis, while <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> used "full orthodox care" and <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> used "customary care". </p> <p>The follow‐up periods varied between the period immediately following HBOT (<a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>), to three weeks (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>), six weeks (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>) eight months (<a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>) and two years (<a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>). <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> reported mortality to discharge from hospital. All included studies reported at least one clinical outcome of interest. Of the outcomes identified above, these trials reported data on both primary outcomes (mortality and MACE), but only length of stay, time to pain relief, magnitude of cardiac enzyme changes, left ventricular function and adverse events from the secondary outcomes of interest. </p> <p>Other outcomes reported included: angiographic re‐stenosis and recurrence of angina (<a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>), left ventricular wall motion score index, diastolic filling and left ventricular end diastolic and systolic volumes (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>), and left ventricular ejection fraction and resolution of ST segment abnormality (<a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>). </p> </section> <section id="CD004818-sec-0041"> <h4 class="title">Excluded studies</h4> <p>A total of five studies were excluded after review of the full report. Details are given in the table <a href="./references#CD004818-sec-0106" title="">Characteristics of excluded studies</a>. Two were reports of animal experiments (<a href="./references#CD004818-bbs2-0008" title="CiocattoE , MoriccaG , QuerciM , CabraiM . Experimental studies on hyperbaric oxygenation. Panminerva Medica1965;7(11):419-24. ">Ciocatto 1965</a>; <a href="./references#CD004818-bbs2-0011" title="ThomasMP , BrownLA , SponsellerDR , WilliamsonSE , DiazJA , GuytonDP . Myocardial infarct size reduction by the synergistic effect of hyperbaric oxygen and recombinant tissue plasminogen activator. American Heart Journal1990;120(4):791-800. ">Thomas 1990</a>), one was a case series (<a href="./references#CD004818-bbs2-0007" title="CameronAJ , GibbBH , LedinghamI . A controlled clinical trial of hyperbaric oxygen in the treatment of acute myocardial infarction. In: LedinghamI , editors(s). Hyperbaric Oxygenation: Proceedings of the Second International Congress. London: ES Livingstone, 1965:277. ">Cameron 1965</a>), one was a non‐random comparative trial (<a href="./references#CD004818-bbs2-0009" title="DaiR , WuJT , LiuLP , WangYQ . Hyperbaric oxygen for coronary heart disease. Chinese Journal of Physical Therapy1995;18:236-7. ">Dai 1995</a>) and one was an RCT which included patients with both stable angina and ACS, and for which the results of those with ACS could not be separately identified (<a href="./references#CD004818-bbs2-0010" title="MarkarianSS , ShirinskaiaGI , StarostinSG , ZagvozkinVN . Comparative study of the effect of drug therapy and its combination with hyperbaric oxygenation and hemosorption on stable angina pectoris [Sravnitel'noe izuchenie vliiania medikamentoznoi terapii i ee sochetanii s giperbaricheskoi oksigenatsiei i gemocorbtsiei na stabil'nuiu stenokardiiu]. Kardiologiia1991;31(9):40-2. ">Markarian 1991</a>). </p> <p>There were no ongoing studies of relevance at the registry <a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a>. </p> </section> </section> <section id="CD004818-sec-0042"> <h3 class="title">Risk of bias in included studies</h3> <p>Details of the quality assessment are given in the Characteristics of included studies table. The significance of variations in quality detailed below is unclear and given that few analyses could be pooled, study quality was not used as a basis for sensitivity analysis. </p> <section id="CD004818-sec-0043"> <h4 class="title">Randomisation</h4> <p>Randomisation procedures were described in <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> (random number tables and computer‐generated sequence respectively) but not in the other studies. Allocation concealment was adequately described only by <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>. For none of the remaining studies is there a clear indication that the investigators were unable to predict the prospective group to which a participant would be allocated. </p> </section> <section id="CD004818-sec-0044"> <h4 class="title">Patient baseline characteristics</h4> <p>All patients required a clinical diagnosis of AMI for enrolment in these studies except <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>, who also enrolled subjects with unstable angina. In general, there were no potentially important differences in baseline characteristics between groups within each study with the exception of <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>. In that study, there were more diabetic patients in the hyperbaric group (22% versus 5%) Three studies defined entry criteria as those patients with a clinical diagnosis of AMI, <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> within the time frame for thrombolysis, <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> within six hours,<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> within 24 hours and <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> from three to seven days after the event. <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> enrolled patients with AMI and abnormal left ventricular wall motion between three and seven days post‐infarct. All patients in the <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> study had presumed coronary arterial lesions where a percutaneous stent was indicated and so were a more highly selected subset of ACS patients. <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>, <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> and <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> indicated that patients who were unstable or in gross left ventricular failure were excluded. </p> </section> <section id="CD004818-sec-0045"> <h4 class="title">Blinding</h4> <p>Only <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> described the use of a sham therapy to blind participants as to treatment group allocation. This paper also described a blinded and randomised method for outcome assessment, including the measurement of concordance between multiple assessors. The echocardiographers were blinded in <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>. </p> </section> <section id="CD004818-sec-0046"> <h4 class="title">Patients lost to follow‐up</h4> <p>The percentage of patients lost to follow up in the six trials ranged from 0% to 13%. <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> and <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> reported no losses to follow‐up or any violation of treatment protocol. <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> reported 16 subjects (12%) withdrawn from analysis after allocation to groups (four became unstable, four generated incomplete data, three were enrolled after six hours in violation of inclusion criteria, two showed no cardiac enzyme rise, two received an incorrect treatment protocol and one refused to have HBOT). <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> similarly did not report data on 13 subjects (6%) who were withdrawn for misdiagnosis or being aged more than 70 years in violation of inclusion criteria. The group allocation was not indicated for any of the withdrawn patients in either of these studies. <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> excluded nine subjects (13%) allocated to HBOT from the analysis, five of which were crossed over to the control arm after declining to receive HBOT. The other four required coronary artery bypass grafting or did not have a lesion suitable for stenting, while there were also four subjects excluded from the control group for the same reasons. <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> reported seven individuals in each group who withdrew early in the treatment phase and at final follow‐up had lost a total of 14 participants (11%). Sensitivity analysis in this review has made best and worse case analyses (with the assumption of equal distribution of withdrawals) to examine potentially important effects on outcome where these studies contributed patients. </p> </section> <section id="CD004818-sec-0047"> <h4 class="title">Intention‐to‐treat analysis</h4> <p>None of the included studies specifically indicated an intention to treat approach, and such an approach was not possible for <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a> as five subjects crossed from HBOT to control for analysis. <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> reported full follow‐up and did not report any protocol violation. </p> </section> </section> <section id="CD004818-sec-0048"> <h3 class="title" id="CD004818-sec-0048">Effects of interventions</h3> <p>See: <a href="./full#CD004818-tbl-0001"><b>Summary of findings 1</b> hyperbaric oxygen therapy for acute coronary syndrome</a>; <a href="./full#CD004818-tbl-0002"><b>Summary of findings 2</b> hyperbaric oxygen therapy for acute coronary syndrome</a> </p> <section id="CD004818-sec-0049"> <h4 class="title">Primary outcomes</h4> <section id="CD004818-sec-0050"> <h5 class="title">1<i>.</i> Death at any time after enrolment (Analysis 1.1) </h5> <p><a href="#CD004818-fig-0002">Figure 2</a><br/>Five trials reported this outcome (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>; <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>; <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>), involving 614 subjects (92% of the total subjects in this review), with 287 (47%) allocated to standard treatment plus HBOT and 327 (53%) to standard therapy alone. <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> contributed 36% of the subjects to this analysis: 21 subjects (7.3%) died in the HBOT group versus 38 (11.6%) in the control group. There was a statistically significant reduction in the risk of death following HBOT (the RR of death with HBOT was 0.58, 95% CI 0.36 to 0.92, P = 0.02). This result, was however sensitive to the allocation of withdrawals (best case RR of death with HBOT is 0.37, 95% CI 0.23 to 0.58, P &lt; 0.001, worst case RR 1.34, 95% CI 0.91 to 1.96, P = 0.14). Subgroup analysis suggested no significant difference between treatment groups for those in cardiogenic shock (RR with cardiogenic shock 0.61 95% CI 0.32 to 1.18, P = 0.15, but a benefit in those without cardiogenic shock (RR 0.57, 95% CI 0.33 to 0.98, P = 0.0.04). There was no indication of significant heterogeneity between trials (I<sup>2</sup> = 0%). Despite the result of the pooled analysis, the absolute risk difference (by simple Х<sup>2</sup> analysis) of 4.3% between control and HBOT is not statistically significant (P = 0.07), with an NNT to avoid one extra death of 24, (95% CI 259 in favour of control to 12 in favour of HBOT). </p> <div class="figure" id="CD004818-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Death, outcome: 1.1 Death at any time." data-id="CD004818-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Death, outcome: 1.1 Death at any time.</p> </div> </div> </div> </section> <section id="CD004818-sec-0051"> <h5 class="title">2. Major Adverse Coronary Events (MACE) (Analysis 2.1)</h5> <p>Only one trial reported this outcome (<a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>), involving 61 patients (9% of the total subjects in this review), with 24 (39%) analysed as receiving standard therapy with HBOT, and 37 (61%) standard therapy alone. One subject (4.2%) suffered with a MACE following HBOT versus 13 subjects (35.1%) in the control group. There was a statistically significant reduction in the risk of MACE following HBOT (RR 0.12, 95% CI 0.02 to 0.85, P = 0.03). This result was however, sensitive to the allocation of withdrawals (best case RR of death with HBOT is 0.09, 95% CI 0.01 to 0.61, P = 0.01, worst case RR 0.56, 95% CI 0.23 to 1.40, P = 0.22). The absolute risk difference of 30.9% between sham and HBOT is significant (P=0.005), with an NNT to avoid one extra MACE of 4, (95% CI 3 to 10). </p> <p>One trial reported the incidence of recurrent acute myocardial infarction (RAMI) at two years rather than MACE (<a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a>), and it was not clear if this included all those who died during the study period. We have therefore reported this outcome separately. This trial included 129 patients (19% of the total subjects in this review), with 65 (50.4%) allocated to control and 64 (49.6%) to HBOT. Three subjects (4.7%) suffered with a RAMI following HBOT versus 11 subjects (16.9%) in the control group.There was a statistically significant reduction in the risk of RAMI following HBOT (RR 0.28, 95% CI 0.08 to 0.95, P = 0.04). This result was however, sensitive to the allocation of withdrawals (best case RR of death with HBOT is 0.17, 95% CI 0.05 to 0.55, P = 0.0003, worst case RR 0.92, 95% CI 0.42 to 2.02, P = 0.84). The absolute risk difference of 12.2% between sham and HBOT is significant (P = 0.03), with an NNT to avoid one extra MACE of 8, (95% CI 4 to 61). </p> </section> </section> <section id="CD004818-sec-0052"> <h4 class="title">Secondary outcomes</h4> <section id="CD004818-sec-0053"> <h5 class="title">3. Significant cardiac events (only significant dysrhythmias were reported) (Analysis 3.1) </h5> <p>Only one trial reported this outcome (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) involving 208 patients (31% of the total subjects in this review), with 103 randomised to receive HBOT and 105 in the control arm. Of the events recorded, three dysrhythmias were accepted as 'significant cardiac events' ‐ complete heart block, ventricular fibrillation and asystole. It is not clear if the numbers reported reflect individuals who suffered these events, or the number of events in total. Overall there were 25 such events reported in the patients receiving HBOT versus 43 such events in the control group, and patients receiving HBOT were significantly less likely to suffer one of these dysrhythmias (RR 0.59, 95% CI 0.39 to 0.89, P = 0.01). The absolute risk reduction of 17% corresponds to an NNT to avoid one event of 6, 95% CI 3 to 24. This result was however sensitive to the allocation of withdrawals, best case RR of significant event with HBOT is 0.51, 95%CI 0.34 to 0.77, P = 0.001, worst case RR 0.73, 95%CI 0.50 to 1.06, P = 0.10).<br/>Separate analyses for each of the three dysrhythmias suggested HBOT patients were significantly less likely to suffer with complete heart block (RR 0.32, 95% CI 0.12 to 0.84, P = 0.02), but not ventricular fibrillation (RR 0.78, 95% CI 0.36 to 1.71, P = 0.54) or asystole (RR 0.73, 95% CI 0.34 to 1.56, P = 0.42). </p> </section> <section id="CD004818-sec-0054"> <h5 class="title">4. Time to relief of cardiac pain (Analysis 4.1)</h5> <p>Only one trial contributed results to this outcome (<a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>) involving 81 subjects (12% of the total), 40 randomised to HBOT and 41 to control: 57 other subjects enrolled did not contribute data to this analysis, our best estimate is that these were 29 in the standard care plus HBOT group and 28 receiving standard care alone. The mean time to pain relief in the HBOT group was 261 minutes versus 614 minutes in the control group and this difference was statistically significant (WMD 353 minutes, 95% CI 219 to 488, P &lt; 0.0001). </p> </section> <section id="CD004818-sec-0055"> <h5 class="title">5. Size of infarct area</h5> <p>No trial reported any data on this outcome.</p> </section> <section id="CD004818-sec-0056"> <h5 class="title">6. Magnitude of cardiac enzyme rise (Analysis 5.2, 5.2, 5.3)</h5> <p>Two trials contributed results to this outcome (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> (as reported in Vlahovic 2004); <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>) involving 184 subjects (28% of the total), 90 randomised to HBOT and 94 to control: 28 other subjects enrolled in <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> did not contribute data to this analysis, 16 in the standard care plus HBOT group and 12 receiving standard care alone. The <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> study reported serum creatine phosphokinase (CPK) levels at 12‐hours post‐treatment and 24‐hours post‐treatment, and both <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> reported the maximum level recorded. The levels at 12 and 24 hours were lower in the <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> patients receiving HBOT, but not statistically significantly so (12hrs‐ MD 138 international units [IU] lower with HBOT, 95% CI 843 lower to 568 higher, P = 0.70; 24 hrs MD 65 IU lower with HBOT, 95% CI 531lower to 401higher, P = 0.78). The maximum level recorded was significantly lower following HBOT (MD 493 IU lower, 95% CI 839 to 148, P = 0.005). </p> </section> <section id="CD004818-sec-0057"> <h5 class="title">7. Left ventricular function (Analysis 6.1 and 6.2)</h5> <p>Three trials reported on improvements in LV function (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>; <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>; <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>). <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> reported the number of individuals in whom improved function could be demonstrated on echocardiography following HBOT, while the other two reported LV ejection fraction (LVEF) at discharge (<a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>), day two and three weeks (<a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a>). <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> also reported several other measures of cardiac function. <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> involved 34 subjects (5% of the total), 24 randomised to HBOT and 10 to control. 12 subjects showed improved contraction in at least one segment in the HBOT group versus zero in the control group. This difference was not, however, statistically significant (RR of improvement without HBOT 0.09, 95% CI 0.01 to 1.4, P = 0.09). <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> and <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> together involved 190 subjects (29% of the total), 94 randomised to HBOT and 96 to control. LVEF was significantly improved in those patients who received HBOT (MD 5.5% better, 95% CI 2.2% to 8.8%, P = 0.001). One control patient in <a href="./references#CD004818-bbs2-0001" title="DeklevaM , NeskovicA , VlahovicA , PutnikovicB , BeleslinB , OstojicM . Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction. American Heart Journal2004;148:e14. VlahovicA , NeskovicAN , DeklevaM , PutnikovicB , PopovicZB , OtasevicP , et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis. American Heart Journal2004;148:e1. ">Dekleva 2004</a> did not contribute to the analysis, while 21 subjects enrolled in the <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> study did not contribute data either, 12 in the HBOT group and 9 in the control. </p> </section> <section id="CD004818-sec-0058"> <h5 class="title">8. Length of stay (Analysis 7.1)</h5> <p>Participants who were given HBOT had a mean stay in hospital of 7.4 days versus 9.2 days for those receiving the control treatment. This difference was not statistically significant (WMD 1.8 days, 95% CI 3.7 to ‐0.1, P = 0.06). Data were from 64 participants in the pilot phase of the <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> study (31 randomised to HBOT and 33 to control) 18 other participants did not contribute data to this analysis (10 from the HBOT arm and 8 from the control arm ). </p> </section> <section id="CD004818-sec-0059"> <h5 class="title">9. Myocardial perfusion</h5> <p>No trials reported any data on this outcome.</p> </section> <section id="CD004818-sec-0060"> <h5 class="title">10. Quality of life</h5> <p>No trials reported any data on this outcome.</p> </section> <section id="CD004818-sec-0061"> <h5 class="title">11. Rate of readmission</h5> <p>No trials reported any data on this outcome.</p> </section> <section id="CD004818-sec-0062"> <h5 class="title">12. Costs of treatment</h5> <p>No trials attempted to estimate the cost‐effectiveness of therapy.</p> </section> </section> <section id="CD004818-sec-0063"> <h4 class="title">Adverse effects</h4> <section id="CD004818-sec-0064"> <h5 class="title">13. Tympanic membrane rupture (TMR), neurological oxygen toxicity and claustrophobia (Analysis 8.1) </h5> <p>Two trials reported on the incidence of tympanic membrane rupture due to barotrauma (<a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) involving 269 subjects (41% of the total), 127 (47%) randomised to HBOT and 142 (53%) randomised to control. One subject suffered TMR in the HBOT group versus none of the controls. This difference was not statistically significant (RR of TMR with HBOT 4.56, 95% CI 0.19 to 107.54, P = 0.35). </p> <p>Three trials (<a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a> (pilot phase); <a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>; <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) involving 274 subjects reported a zero incidence of neurological oxygen toxicity in all arms. No trial reported on any adverse effects in relation to standard therapeutic measures.<br/>One trial reported on claustrophobia (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) involving 208 subjects (31% of the total), 103 (50%) randomised to HBOT and 105 (50%) to control. There were 15 subjects (15%) with claustrophobia requiring cessation of therapy in the HBOT group versus none in the control group. This difference is statistically significant (RR of claustrophobia with HBOT 31.6, 95% CI 1.92 to 521, P = 0.02). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004818-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004818-sec-0065"></div> <section id="CD004818-sec-0066"> <h3 class="title" id="CD004818-sec-0066">Summary of main results</h3> <p>This review has included data from six trials investigating the treatment of ACS with HBOT, and we believe these represent all randomised human trials in this area, both published and unpublished, at the time of searching. One trial included subjects with ACS, while five included only subjects with confirmed myocardial infarction. </p> <p>Pooled data for clinical outcomes of interest were performed with respect to the risk of death, cardiac enzyme peak levels, left ventricular function and adverse effects. CPK rose significantly less following HBOT (MD 493 IU, P = 0.005), implying a smaller volume of infarction, and LVEF was better following HBOT (MD 5.5%, P = 0.001) . The clinical and functional significance of these differences is not clear. The risk of dying was significantly better following HBOT, (RR 0.58, P = 0.02) and the absolute risk difference of 4.3% suggested an NNT of around 24 patients in order to avoid one death by the addition of HBOT. Only one trial (<a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a>) reported the fate of those presenting in cardiogenic shock, and while there was no statistically significant difference between groups in this small sample, it is worth noting that all survivors were from the HBOT group (three from seven subjects versus none from five). The one small study that reported MACE rather than death alone (<a href="./references#CD004818-bbs2-0004" title="SharifiM , FaresW , Abdel-KarimI , KochJM , SopkoJ , AdlerD . Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris. American Journal of Cardiology2004;93(June 15):1533-5. SharifiM , FaresW , Abdel-KarimI , PetreaD , KochJM , AdlerD , et al. Inhibition of restenosis by hyperbaric oxygen: a novel indication for an old modality. Cardiovascular Radiation Medicine2002;3:124-6. ">Sharifi 2004</a>) also suggested better outcome with the use of HBOT (RR 0.12, P = 0.03) with a risk difference of 31% and an NNT of 4. Similarly, <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> reported a significant reduction in the chance of re‐infarction with the administration of HBOT (RR 0.28, P = 0.04) with a risk difference of 12..2% and an NNT of 8. These possible treatment effects would be of great clinical importance and deserve further investigation. </p> </section> <section id="CD004818-sec-0067"> <h3 class="title" id="CD004818-sec-0067">Overall completeness and applicability of evidence</h3> <p>Only six trials with 665 participants were available for evaluation using our planned comparisons, and meta‐analysis was not appropriate or possible for a number of these. The evidence is therefore very incomplete and cannot be applied directly to routine clinical care for patients with acute coronary syndrome. </p> <p>These trials were published over a 24‐year period up to 2007, and from a wide geographical area. We had planned to perform subgroup analyses with respect to inclusion or otherwise of thrombolysis, the nature of comparator treatments, dose of oxygen received (pressure, time and length of treatment course), the presence or absence of cardiac failure, the site of infarct, and to compare those with established versus pre‐infarct subjects. However, the paucity of eligible trials and poor reporting suggested these analyses would not be informative. Patient inclusion criteria were not standard, and poorly reported in some trials. Only <a href="./references#CD004818-bbs2-0003" title="DeklevaMN , OstojicM , VujnovicD . Hyperbaric oxygen and thrombolysis in acute myocardial infarction: a preliminary report. In: SitinenSA , LeinioM , editors(s). Proceedings of the Twenty-first Annual Meeting of the European Underwater and Baromedical Society (EUBS). Helsinki: EUBS, 1995:9-13. ShandlingAH , EllestadMH , HartGB , CrumpR , MarlowD , Van NattaB , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: The &quot;HOT MI&quot; pilot study. American Heart Journal1997;134:544-50. StavitskyY , ShandlingAH , EllestadMH , HartGB , Van NattaB , MessengerJC , et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the 'HOT MI' randomised multicenter study. Cardiology1998;90:131-6. ">Hot MI 1998</a>, <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a> and <a href="./references#CD004818-bbs2-0002" title="Aliprandi-CostaB , RanasingheI , ChowV , KapilaS , JuergensC , DevlinG , et la. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. MJA2011;195(3):116-21. DotsenkoEA , SalivonchikOP , KozyroVI . Long term results of the use of hyperbaric oxygenation in patients with acute myocardial infarction. Kardiologiia2007;12:53-6. DotsenkoEA , SalivonchikOP , NikulinaN , WelcomeMO . The influence of hyperbaric oxygenation therapy on recurrent myocardial infarction and two-year survival rate in acute myocardial infarction patients. Port Harcourt Medical Journal2009;3(3):256-63. ">Dotsenko 2007</a> clearly indicated the time at which the inclusion criteria were applied. There was significant variation both in oxygen dose during an individual treatment session, and in the number of sessions administered to each patient. While all trials used some form of 'standard' cardiac therapy in a dedicated unit designed to maximise outcome, these comparator therapies were generally poorly described and could not form the basis for a meaningful subgroup analysis. </p> </section> <section id="CD004818-sec-0068"> <h3 class="title" id="CD004818-sec-0068">Quality of the evidence</h3> <p>As well as carrying little statistical power, other problems for this review were the variable methodological quality of many of these trials, differences in entry criteria and the nature and timing of outcomes, and poor reporting of both outcomes and methodology. In particular, there is a possibility of bias due to different anatomical locations and extent of myocardial damage on entry to these small trials, as well as from non‐blinded management decisions in all except <a href="./references#CD004818-bbs2-0005" title="SwiftPC , TurnerJH , OxerHF , O'SeaJP , LaneGK , WoollardKV . Myocardial hibernation identified by hyperbaric oxygen treatment and echocardiography in postinfarction patients: comparison with exercise thallium scintigraphy. American Heart Journal1992;124:1151-8. ">Swift 1992</a>. Further, we could only pool the data for two of our outcomes of interest given little commonality between the outcomes reported in these trials. </p> <p>For the primary outcomes, only a single trial clearly recorded all major adverse copronary events (MACE) and we were unable to calculate a pooled estimate of the effect of allocation to receive HBOT. For the risk of death following acute cortonary syndrome, our estmate is that patients allocated to HBOT were associated with a reduction in the risk of death by around 42% (RR: 0.58, (95% CI 0.36 to 0.92). This estimate was derived from only five trials including 614 subjects and the GRADE approach rates this evidence as of low quality following downgrading because this critical outcome had a low incidence in this small group of patients. </p> <p>For our secondary outcomes, we could pool only the maximum plasma creatine phosphate (CPK) for two trials. Using the GRADE approach, the evidence for lower CPK associated with patients who received HBOT was rated as high. </p> <p>As is common with small trials, the incidence of adverse effects was poorly assessed by the studies included in this review. No trial reported any neurological or pulmonary oxygen toxicity in any group, while there was only one reported case of severe ear barotrauma as a consequence of compression. <a href="./references#CD004818-bbs2-0006" title="ThurstonGJ , GreenwoodTW , BendingMR , ConnorH , CurwenMP . A controlled investigation into the effects of hyperbaric oxygen on mortality following acute myocardial infarction. Quarterly Journal of Medicine1973;XLII:751-70. ">Thurston 1973</a> reported 15 individuals who needed to be removed from a single occupancy hyperbaric chamber because of claustrophobia, a rate of 15%. While this is a clinically significant problem in that trial, it is unlikely this rate would be sustained when using larger compression chambers designed for multiple occupancy. There are a number of more minor complications that may occur commonly. Visual disturbance, usually reduction in visual acuity secondary to conformational changes in the lens, is very commonly reported ‐ perhaps as many as 50% of those having a course of 30 treatments (<a href="./references#CD004818-bbs2-0027" title="KhanB , EvansAW , EasterbrookM . Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea and Hyperbaric Medicine2003;24:9.">Khan 2003</a>). While the great majority of patients recover spontaneously over a period of days to weeks, a small proportion of patients continue to require correction to restore sight to pre‐treatment levels. None of the trials included in this review reported visual changes. The second most common adverse effect associated with HBOT is middle‐ear barotrauma. Barotrauma can affect any air‐filled cavity in the body (including the middle ear, lungs and respiratory sinuses) and occurs as a direct result of compression. Ear barotrauma is by far the most common as the middle ear air space is small, largely surrounded by bone and the sensitive tympanic membrane, and usually requires active effort by the patient in order to inflate the middle ear through the eustachian tube on each side. Barotrauma is thus not a consequence of HBOT directly, but rather of the physical conditions required to administer it. Most episodes of barotrauma are mild, easily treated or recover spontaneously and do not require the therapy to be abandoned. </p> </section> <section id="CD004818-sec-0069"> <h3 class="title" id="CD004818-sec-0069">Potential biases in the review process</h3> <p>The authors of this review have no conflict of interest to declare and none are authors of any literature contributing to this review. We believe we have conducted this review without bias. All of these findings are, however, subject to a potential publication bias. While we have made every effort to locate further unpublished data, it remains possible that this review is subject to a positive publication bias, with generally favourable trials more likely to achieve reporting. With regard to any effect on the quality of life for these patients, we have located no relevant data. </p> </section> <section id="CD004818-sec-0070"> <h3 class="title" id="CD004818-sec-0070">Agreements and disagreements with other studies or reviews</h3> <p>Although there has been relatively little clinical literature on this subject, these encouraging findings are in general agreement with opinion in the literature <a href="./references#CD004818-bbs2-0018" title="EllestadMH . Hyperbaric oxygen: its application in cardiology: a historical perspective and personal journey. Cardiology Review2009;17(6):280-2.">Ellestad 2009</a>. We are not aware of any other formal systematic reviews of the literature. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004818-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD004818-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Death, outcome: 1.1 Death at any time." data-id="CD004818-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Death, outcome: 1.1 Death at any time.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Death, Outcome 1: Death at any time" data-id="CD004818-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Death, Outcome 1: Death at any time</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Death, Outcome 2: Death ‐ best case scenario" data-id="CD004818-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Death, Outcome 2: Death ‐ best case scenario</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Death, Outcome 3: Death ‐ worst case scenario" data-id="CD004818-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Death, Outcome 3: Death ‐ worst case scenario</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 1: Major Adverse Cardiac Events" data-id="CD004818-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 1: Major Adverse Cardiac Events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 2: MACE ‐ Best case scenario" data-id="CD004818-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 2: MACE ‐ Best case scenario</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 3: MACE ‐ worst case scenario" data-id="CD004818-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 3: MACE ‐ worst case scenario</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 4: Recurrent acute myocardial infarction (AMI)" data-id="CD004818-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 4: Recurrent acute myocardial infarction (AMI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 5: Recurrent AMI ‐ best case scenario" data-id="CD004818-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 5: Recurrent AMI ‐ best case scenario</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Major Adverse Cardiac Events, Outcome 6: Recurrent AMI ‐ Worst case scenario" data-id="CD004818-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Major Adverse Cardiac Events, Outcome 6: Recurrent AMI ‐ Worst case scenario </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 1: Overall (CHB, VF and asystole combined)" data-id="CD004818-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 1: Overall (CHB, VF and asystole combined) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 2: Significant dysrrythmias (complete heart block, ventricular fibrillation or asystole)" data-id="CD004818-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 2: Significant dysrrythmias (complete heart block, ventricular fibrillation or asystole) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 3: Overall best case" data-id="CD004818-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 3: Overall best case </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 4: Overall worst case" data-id="CD004818-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole), Outcome 4: Overall worst case </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Time to pain relief, Outcome 1: Time to relief of pain" data-id="CD004818-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Time to pain relief, Outcome 1: Time to relief of pain</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Magnitude of cardiac enzyme changes, Outcome 1: 12 hour Plasma Creatine Phosphokinase" data-id="CD004818-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Magnitude of cardiac enzyme changes, Outcome 1: 12 hour Plasma Creatine Phosphokinase </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Magnitude of cardiac enzyme changes, Outcome 2: 24 hour Plasma Creatine Phosphate" data-id="CD004818-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Magnitude of cardiac enzyme changes, Outcome 2: 24 hour Plasma Creatine Phosphate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Magnitude of cardiac enzyme changes, Outcome 3: Maximum Plasma Creatine Phosphate" data-id="CD004818-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Magnitude of cardiac enzyme changes, Outcome 3: Maximum Plasma Creatine Phosphate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Improvement in left ventricular function, Outcome 1: Improved contraction in at least one segment (post‐HBOT echo)" data-id="CD004818-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Improvement in left ventricular function, Outcome 1: Improved contraction in at least one segment (post‐HBOT echo) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Improvement in left ventricular function, Outcome 2: Left Ventricular Ejection Fraction‐ % (final estimate)" data-id="CD004818-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Improvement in left ventricular function, Outcome 2: Left Ventricular Ejection Fraction‐ % (final estimate) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Length of Stay, Outcome 1: Overall length of stay (days)" data-id="CD004818-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Length of Stay, Outcome 1: Overall length of stay (days)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004818-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/urn:x-wiley:14651858:media:CD004818:CD004818-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Adverse events of therapy, Outcome 1: Total adverse events" data-id="CD004818-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_t/tCD004818-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Adverse events of therapy, Outcome 1: Total adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/media/CDSR/CD004818/image_n/nCD004818-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004818-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>hyperbaric oxygen therapy for acute coronary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute coronary syndrome<br/><b>Settings:</b> Acute care hospital<br/><b>Intervention:</b> hyperbaric oxygen therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>hyperbaric oxygen therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death at any time</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.58</b> <br/>(0.36 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>614<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>116 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b><br/>(42 to 107) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Medium risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>102 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/>(37 to 94) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. <br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Critical outcome<br/><sup>2</sup> Small sample with low numbers of events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004818-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>hyperbaric oxygen therapy for acute coronary syndrome</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute coronary syndrome<br/><b>Settings:</b> acute care hospital<br/><b>Intervention:</b> hyperbaric oxygen therapy </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>hyperbaric oxygen therapy</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12 hour Plasma Creatine Phosphokinase</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 12 hour Plasma Creatine Phosphokinase in the intervention groups was<br/><b>138 lower</b><br/>(843.83 lower to 567.83 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>24 hour Plasma Creatine Phosphate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean 24 hour Plasma Creatine Phosphate in the intervention groups was<br/><b>65 lower</b><br/>(530.96 lower to 400.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maximum Plasma Creatine Phosphate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Maximum Plasma Creatine Phosphate in the intervention groups was<br/><b>493.16 lower</b><br/>(838.74 to 147.58 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/><b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Single trial only </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">hyperbaric oxygen therapy for acute coronary syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/full#CD004818-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Death</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Death at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.36, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Subjects presenting in cardiogenic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.32, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Subjects presenting without cardiogenic shock</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>602</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.33, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Death ‐ best case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.23, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Death ‐ worst case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.91, 1.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Death</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Major Adverse Cardiac Events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Major Adverse Cardiac Events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.02, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 MACE ‐ Best case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 MACE ‐ worst case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.23, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Recurrent acute myocardial infarction (AMI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.08, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Recurrent AMI ‐ best case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.05, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Recurrent AMI ‐ Worst case scenario <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.42, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Major Adverse Cardiac Events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Overall (CHB, VF and asystole combined) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.39, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Significant dysrrythmias (complete heart block, ventricular fibrillation or asystole) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Complete heart block</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Ventricular fibrillation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.36, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Asystole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.34, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Overall best case <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.34, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Overall worst case <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Significant dysrhythmias (complete heart block, ventricular fibrillation, asystole)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Time to pain relief</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Time to relief of pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐353.00 [‐487.55, ‐218.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Time to pain relief</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Magnitude of cardiac enzyme changes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 12 hour Plasma Creatine Phosphokinase <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐138.00 [‐843.83, 567.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 24 hour Plasma Creatine Phosphate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐65.00 [‐530.96, 400.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Maximum Plasma Creatine Phosphate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐493.16 [‐838.74, ‐147.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Magnitude of cardiac enzyme changes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Improvement in left ventricular function</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Improved contraction in at least one segment (post‐HBOT echo) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Left Ventricular Ejection Fraction‐ % (final estimate) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.47 [2.19, 8.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Improvement in left ventricular function</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Length of Stay</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Overall length of stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐3.70, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Length of Stay</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004818-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Adverse events of therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Total adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Tympanic membrane rupture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.56 [0.19, 107.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 Acute neurological oxygen toxicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.3 Claustrophobia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>31.60 [1.92, 521.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Adverse events of therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004818.pub4/references#CD004818-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004818.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004818-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004818-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD004818-note-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD004818-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004818-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004818-note-0009">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004818-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004818\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004818\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004818\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004818\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004818\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=tlnpj831&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004818.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004818.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004818.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004818.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004818.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727055327"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004818.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727055330"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004818.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea2ba5d2ef401',t:'MTc0MDcyNzA1NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 